BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 86 filers reported holding BIOLIFE SOLUTIONS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $869,000 | -41.5% | 91,501 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $1,485,000 | +2.5% | 91,761 | +5.3% | 0.00% | 0.0% |
| Q3 2019 | $1,449,000 | -60.3% | 87,161 | -59.5% | 0.00% | -66.7% |
| Q2 2019 | $3,652,000 | +1.7% | 215,449 | +7.4% | 0.00% | -25.0% |
| Q1 2019 | $3,590,000 | – | 200,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
| Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
| Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
| Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
| GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
| Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
| Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
| Penbrook Management LLC | 41,500 | $917,150 | 0.66% |